Economic costs for outpatient treatment of eating disorders in Japan.
Eating Disorder Examination Questionnaire
Eating disorders
Economic costs
Outpatients
Psychosomatic Medicine
Reimbursement
Journal
Journal of eating disorders
ISSN: 2050-2974
Titre abrégé: J Eat Disord
Pays: England
ID NLM: 101610672
Informations de publication
Date de publication:
14 Aug 2023
14 Aug 2023
Historique:
received:
16
04
2023
accepted:
08
08
2023
medline:
15
8
2023
pubmed:
15
8
2023
entrez:
14
8
2023
Statut:
epublish
Résumé
Few studies have examined the economic costs of outpatient care for eating disorders in Japan. This study aimed to clarify the reimbursement for outpatient treatment of eating disorders and compare the costs between the departments of Psychosomatic Medicine and Psychiatry in Japan. A multicenter, prospective, observational study of patients with an eating disorder was conducted in the Psychosomatic Medicine departments of three centers and the Psychiatry departments of another three centers in Japan. We analyzed medical reimbursement for an outpatient revisit, time of clinical interviews, and the treatment outcome measured by the Eating Disorder Examination Questionnaire (EDE-Q) global scores and body mass index (BMI) at 3 months. Multivariate linear regression models were performed to adjust for covariates. This study included 188 patients in the Psychosomatic Medicine departments and 68 in the Psychiatry departments. The average reimbursement cost for an outpatient revisit was 4670 yen. Even after controlling for covariates, the Psychosomatic Medicine departments had lower reimbursement points per minute of interviews than the Psychiatry departments (coefficient = - 23.86; 95% confidence interval = - 32.09 to - 15.63; P < 0.001). In contrast, EDE-Q global scores and BMI at 3 months were not significantly different between these departments. This study clarifies the economic costs of treating outpatients with eating disorders in Japan. The medical reimbursement points per interview minute were lower in Psychosomatic Medicine departments than in Psychiatry departments, while there were no apparent differences in the treatment outcomes. Addressing this issue is necessary to provide an adequate healthcare system for patients with eating disorders in Japan. This study examined the cost of outpatient care for eating disorders in Japan, comparing treatment costs between the Psychosomatic Medicine and Psychiatry departments. The actual cost of outpatient care for eating disorders in Japan was clarified. The results indicate that Psychosomatic Medicine departments have lower reimbursement points per interview time compared to the Psychiatry departments, but there were no noticeable differences in treatment outcomes between the two. This highlights the need to address this cost difference to improve the healthcare system for patients with eating disorders in Japan.
Sections du résumé
BACKGROUND
BACKGROUND
Few studies have examined the economic costs of outpatient care for eating disorders in Japan. This study aimed to clarify the reimbursement for outpatient treatment of eating disorders and compare the costs between the departments of Psychosomatic Medicine and Psychiatry in Japan.
METHOD
METHODS
A multicenter, prospective, observational study of patients with an eating disorder was conducted in the Psychosomatic Medicine departments of three centers and the Psychiatry departments of another three centers in Japan. We analyzed medical reimbursement for an outpatient revisit, time of clinical interviews, and the treatment outcome measured by the Eating Disorder Examination Questionnaire (EDE-Q) global scores and body mass index (BMI) at 3 months. Multivariate linear regression models were performed to adjust for covariates.
RESULTS
RESULTS
This study included 188 patients in the Psychosomatic Medicine departments and 68 in the Psychiatry departments. The average reimbursement cost for an outpatient revisit was 4670 yen. Even after controlling for covariates, the Psychosomatic Medicine departments had lower reimbursement points per minute of interviews than the Psychiatry departments (coefficient = - 23.86; 95% confidence interval = - 32.09 to - 15.63; P < 0.001). In contrast, EDE-Q global scores and BMI at 3 months were not significantly different between these departments.
CONCLUSIONS
CONCLUSIONS
This study clarifies the economic costs of treating outpatients with eating disorders in Japan. The medical reimbursement points per interview minute were lower in Psychosomatic Medicine departments than in Psychiatry departments, while there were no apparent differences in the treatment outcomes. Addressing this issue is necessary to provide an adequate healthcare system for patients with eating disorders in Japan.
This study examined the cost of outpatient care for eating disorders in Japan, comparing treatment costs between the Psychosomatic Medicine and Psychiatry departments. The actual cost of outpatient care for eating disorders in Japan was clarified. The results indicate that Psychosomatic Medicine departments have lower reimbursement points per interview time compared to the Psychiatry departments, but there were no noticeable differences in treatment outcomes between the two. This highlights the need to address this cost difference to improve the healthcare system for patients with eating disorders in Japan.
Autres résumés
Type: plain-language-summary
(eng)
This study examined the cost of outpatient care for eating disorders in Japan, comparing treatment costs between the Psychosomatic Medicine and Psychiatry departments. The actual cost of outpatient care for eating disorders in Japan was clarified. The results indicate that Psychosomatic Medicine departments have lower reimbursement points per interview time compared to the Psychiatry departments, but there were no noticeable differences in treatment outcomes between the two. This highlights the need to address this cost difference to improve the healthcare system for patients with eating disorders in Japan.
Identifiants
pubmed: 37580766
doi: 10.1186/s40337-023-00864-2
pii: 10.1186/s40337-023-00864-2
pmc: PMC10426034
doi:
Types de publication
Journal Article
Langues
eng
Pagination
136Subventions
Organisme : Ministry of Health, Labour and Welfare
ID : H26-001
Organisme : Ministry of Health, Labour and Welfare
ID : H26-001
Informations de copyright
© 2023. BioMed Central Ltd., part of Springer Nature.
Références
van Eeden AE, van Hoeken D, Hoek HW. Incidence, prevalence and mortality of anorexia nervosa and bulimia nervosa. Curr Opin Psychiatry. 2021;34:515–24.
doi: 10.1097/YCO.0000000000000739
pubmed: 34419970
pmcid: 8500372
Kurisu K, Matsuoka M, Sato K, et al. Increased prevalence of eating disorders in Japan since the start of the COVID-19 pandemic. Eat Weight Disord. 2022;27:2251–5.
doi: 10.1007/s40519-021-01339-6
pubmed: 34855142
Streatfeild J, Hickson J, Austin SB, et al. Social and economic cost of eating disorders in the United States: evidence to inform policy action. Int J Eat Disord. 2021;54:851–68.
doi: 10.1002/eat.23486
pubmed: 33655603
National Institute for Health and Care Excellence. Eating disorders: recognition and treatment NICE guideline [NG69]. London: NICE; 2017.
Fairburn CG. Cognitive behavior therapy and eating disorders. 16th ed. New York: Guilford Press; 2008.
Ágh T, Kovács G, Supina D, et al. A systematic review of the health-related quality of life and economic burdens of anorexia nervosa, bulimia nervosa, and binge eating disorder. Eat Weight Disord. 2016;21:353–64.
doi: 10.1007/s40519-016-0264-x
pubmed: 26942768
pmcid: 5010619
Byford S, Barrett B, Roberts C, et al. Economic evaluation of a randomised controlled trial for anorexia nervosa in adolescents. Br J Psychiatry. 2007;191:436–40.
doi: 10.1192/bjp.bp.107.036806
pubmed: 17978324
Lock J, Couturier J, Agras WS. Costs of remission and recovery using family therapy for adolescent anorexia nervosa: a descriptive report. Eat Disord. 2008;16:322–30.
doi: 10.1080/10640260802115969
pubmed: 18568922
Pohjolainen V, Räsänen P, Roine RP, et al. Cost-utility of treatment of bulimia nervosa. Int J Eat Disord. 2010;43:596–602.
doi: 10.1002/eat.20754
pubmed: 19806609
Ministry of Health, Labour and Welfare. MLHW grants system. Research on the treatment system for eating disorders; 2017. https://mhlw-grants.niph.go.jp/system/files/2016/162091/201616020B_upload/201616020B0004.pdf . Accessed 24 June 2023 (in Japanese).
Yoshiuchi K. How can psychosomatic physicians contribute to behavioral medicine? Biopsychosoc Med. 2016;10:8.
doi: 10.1186/s13030-016-0060-x
pubmed: 26941833
pmcid: 4776445
Ohara C, Sekiguchi A, Takakura S, et al. Effectiveness of enhanced cognitive behavior therapy for bulimia nervosa in Japan: a randomized controlled trial protocol. Biopsychosoc Med. 2020;14:2.
doi: 10.1186/s13030-020-0174-z
pubmed: 32123540
pmcid: 7041176
Ministry of Health, Labour and Welfare. Medical reimbursement points. https://www.mhlw.go.jp/content/12404000/000907834.pdf . Accessed 24 June 2023 (in Japanese).
American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 5th edn. (DSM-5). Arlington, VA: American Psychiatric Association (2013).
Nakai Y, Nin K, Fukushima M, et al. Eating disorder examination questionnaire (EDE-Q): norms for undergraduate Japanese women. Eur Eat Disord Rev. 2014;22:439–42.
doi: 10.1002/erv.2324
pubmed: 25257360
Ministry of Health, Labour and Welfare. Patients’ coverage of medical costs. https://www.mhlw.go.jp/bunya/shakaihosho/iryouseido01/info02d-37.html . Accessed 24 June 2023 (in Japanese).
Solmi M, Wade TD, Byrne S, et al. Comparative efficacy and acceptability of psychological interventions for the treatment of adult outpatients with anorexia nervosa: a systematic review and network meta-analysis. Lancet Psychiatry. 2021;8:215–24.
doi: 10.1016/S2215-0366(20)30566-6
pubmed: 33600749
Atwood ME, Friedman A. A systematic review of enhanced cognitive behavioral therapy (CBT-E) for eating disorders. Int J Eat Disord. 2020;53:311–30.
doi: 10.1002/eat.23206
pubmed: 31840285
Haynos AF, Wang SB, Lipson S, et al. Machine learning enhances prediction of illness course: a longitudinal study in eating disorders. Psychol Med. 2021;51:1392–402.
doi: 10.1017/S0033291720000227
pubmed: 32108564
Meule A, Kolar DR, Rauh E, et al. Comparing illness duration and age as predictors of treatment outcome in female inpatients with anorexia nervosa. Eat Disord. 2023;31:274–84.
doi: 10.1080/10640266.2022.2114586
pubmed: 36178330